Compounds and Radioligands for Targeting Neurotensin Receptor and Uses Thereof
Copyright © Targeted News Service 2024
2024-11-19
ALEXANDRIA, Virginia, Nov. 19 -- FULL-LIFE TECHNOLOGIES HK LIMITED, Admiralty, China has been assigned a patent (No. US 12145926 B2, initially filed March 13, 2024) developed by Fa Liu, Watchung, New Jersey, for "Compounds and radioligands for targeting neurotensin receptor and uses thereof." . . .